MedTrace Logo

The TOGETHER Project - Liver

NCT03874286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2022-05-20

No results posted yet for this study

Summary

To validate the use of a RNAseq-based peripheral blood assay in liver transplant recipients when correlated to liver biopsy results.

Conditions

  • Liver Transplant Rejection

Interventions

DIAGNOSTIC_TEST

Liver Transplant

Patients will obtain a research blood draw and a liver biopsy at 4 months and 12 months post transplant. Liver biopsies are routinely performed in the liver transplant population. We will be obtaining a liver biopsy at this particular time point to compare the biopsy results with the peripheral blood results.

Sponsors & Collaborators

Principal Investigators

  • Mark Stegall, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-15
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03874286 on ClinicalTrials.gov